Antiobesogenic and Antiatherosclerotic Properties of Caralluma fimbriata Extract

Abstract EN

There is evidence that the principles present in the widely consumed Indian food plant C.

fimbriata extract (CFE) suppress appetite, and provide antiobesogenic and metabolic benefits.

The Diet-Induced Obesity (DIO) rat model was used to investigate CFE's anorexigenic effects.

Rats were randomly divided into three groups: (i) untreated control (C), (ii) control for cafeteria diet (CA), and (iii) cafeteria diet fed + CFE treated.

Rats in the test group received cafeteria diet and CFE from day one onwards.

CFE was administered by gavage at three doses (25, 50, 100 mg/Kg BW per day) for 90 days.

The antiobesogenic effects of CFE were evaluated by monitoring changes in feed intake, body weight, serum lipid and hormonal (leptin) profiles, fat pads, and liver weight.

Antiatherosclerotic effects were measured by histology.

CFE induced significant and dose-dependent inhibition of food intake, with dose-related prevention of gains in body weight, liver weight, and fat pad mass.

Alterations in serum lipid profiles associated with weight gain were similarly inhibited, as were the typical increases in serum leptin levels.

These data substantiate CFE's reported anorexigenic effects.

CFE treatment also conferred protection against atherogenesis.

We conclude that CFE possesses antiobesogenic and antiatherosclerotic properties.